Pietro Scalfaro

Pietro is in charge of strategy and operational management of early-stage clinical drug development at ENYO Pharma. He has a wide range experience in this role in the healthcare sector, working notably in infectious diseases (HCV, via the development of Alisporivir), septicaemia, oncology, Alzheimer’s disease and cardio-respiratory diseases.

Pietro also set up a Personalised Medicine Business Unit at Debiopharm Group and is involved in Swiss eHealth start-up companies. He is a physician, with a degree from the University of Lausanne, certificates in Pediatrics and Intensive Care, and holds an MBA.